Relmada Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
31 Jan 24 | BuyUS$150,920 | Charles Ence | Individual | 38,970 | US$4.05 | |
31 Jan 24 | BuyUS$125,717 | Maged Shenouda | Individual | 32,675 | US$4.06 | |
31 Jan 24 | BuyUS$386,738 | Sergio Traversa | Individual | 100,000 | US$4.00 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 2,415,243 | 8% |
General Public | 13,449,835 | 44.6% |
Institutions | 14,309,124 | 47.4% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,899,930 | US$7.6m | 0% | no data | |||
1,256,705 | US$5.0m | -4.13% | no data | |||
1,240,034 | US$4.9m | -39.4% | 0.12% | |||
1,200,000 | US$4.8m | 943% | 0.38% | |||
1,181,186 | US$4.7m | -0.14% | 0.01% | |||
975,945 | US$3.9m | 0.25% | 0.25% | |||
759,000 | US$3.0m | -13.5% | 0.63% | |||
732,400 | US$2.9m | 0% | 0.26% | |||
630,251 | US$2.5m | 0% | no data | |||
578,188 | US$2.3m | 0.95% | no data | |||
341,450 | US$1.4m | 71.7% | no data | |||
326,200 | US$1.3m | -0.64% | no data | |||
256,087 | US$1.0m | 5.21% | no data | |||
244,024 | US$971.2k | 69.4% | no data | |||
227,039 | US$903.6k | -25% | no data | |||
224,846 | US$894.9k | 0% | no data | |||
210,576 | US$838.1k | -0.03% | no data | |||
207,870 | US$827.3k | 35.4% | no data | |||
195,777 | US$779.2k | 15.1% | 0.01% | |||
191,000 | US$760.2k | -9.95% | 0.93% | |||
187,295 | US$745.4k | 0% | no data | |||
184,338 | US$733.7k | 16.4% | 0.03% | |||
175,978 | US$700.4k | 836% | no data | |||
175,229 | US$697.4k | 1,340% | no data | |||
165,474 | US$658.6k | 0% | 0.04% |